This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 12496 results found since Jan 2013.
< em > Letter to Editor: < /em > Observations of Deception in Urine Drug Testing
CONCLUSION: Deception can be identified using the metabolite/parent drug ratio.PMID:37625839
Source: Annals of Clinical and Laboratory Science - August 25, 2023 Category: Laboratory Medicine Authors: Agnes Cua Kevin Krock Richard Thomas Amadeo Pesce Source Type: research
Maternal Brain Imaging in Opioid Use Disorder
Conditions: Opioid Use Disorder; Substance-Related Disorders; Substance Use; Pregnancy Related; Narcotic-Related Disorders; Buprenorphine Dependence Interventions: Drug: Buprenorphine; Diagnostic Test: Maternal Brain MRI; Other: Blood Samples; Behavioral: Questionnaires Sponsors: Indiana University; National Institute on Drug Abuse (NIDA) Recruiting
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials
Medicare coverage of buprenorphine-naloxone film surrounding generic entry
CONCLUSIONS: Medicare Part D plan formularies replaced brand-name buprenorphine-naloxone films with the newly approved generic versions. This was accompanied by a substantial decrease in estimated OOP cost faced by Part D enrollees. These changes could potentially increase access to buprenorphine among Medicare enrollees with opioid use disorder.PMID:37616154 | DOI:10.37765/ajmc.2023.89413
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: Hao Zhang Yuhua Bao Shashi N Kapadia Source Type: research
